Nexalin Technology, Inc. (NXLIW) Financial Statements (2026 and earlier)

Company Profile

Business Address 1776 YORKTOWN
HOUSTON, TX 77056
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,4802,9486,994
Cash and cash equivalent574580163
Short-term investments2,9052,3686,831
Receivables1395
Inventory, net of allowances, customer advances and progress billings175156154
Inventory175156154
Other undisclosed current assets294316272
Total current assets:3,9613,4307,425
Noncurrent Assets
Operating lease, right-of-use asset  06
Property, plant and equipment  (3)1
Long-term investments and receivables 196 
Long-term investments 196 
Intangible assets, net (including goodwill)26195 
Intangible assets, net (excluding goodwill)26195 
Other undisclosed noncurrent assets  13 
Total noncurrent assets:2622027
TOTAL ASSETS:4,2233,6327,432
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5474211,198
Accounts payable156160658
Accrued liabilities391261540
Debt   500
Other undisclosed current liabilities  4251
Total current liabilities:5474251,949
Noncurrent Liabilities
Liabilities, other than long-term debt   4
Operating lease, liability   4
Total noncurrent liabilities:   4
Total liabilities:5474251,953
Equity
Equity, attributable to parent, including:3,6763,2075,479
Common stock1377
Additional paid in capital88,30880,23877,824
Deferred compensation equity (323)(215)(23)
Accumulated other comprehensive income (loss)(1)(0)36
Accumulated deficit(84,645)(77,038)(72,389)
Other undisclosed equity, attributable to parent 32321523
Total equity:3,6763,2075,479
TOTAL LIABILITIES AND EQUITY:4,2233,6327,432

Income Statement (P&L) ($ in thousands)

9/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
Revenues1691111,321
Other income9240172
Cost of revenue(37)(26)(363)
Cost of product and service sold  (6)(20)
Gross profit:13285958
Operating expenses(7,887)(5,781)(2,791)
Operating loss:(7,755)(5,696)(1,833)
Nonoperating income1431,048135
Other nonoperating income139  
Interest and debt expense  615(59)
Other undisclosed loss from continuing operations before equity method investments, income taxes   
Loss from continuing operations:(7,612)(4,034)(1,757)
Other undisclosed net income5  
Net loss:(7,607)(4,034)(1,757)
Other undisclosed net income (loss) attributable to parent  (615)59
Net loss available to common stockholders, diluted:(7,607)(4,649)(1,698)

Comprehensive Income ($ in thousands)

9/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
Net loss:(7,607)(4,034)(1,757)
Other comprehensive income (loss)(0)(37)36
Other undisclosed comprehensive loss   
Comprehensive loss:(7,607)(4,070)(1,721)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (615)59
Comprehensive loss, net of tax, attributable to parent:(7,607)(4,685)(1,662)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: